Methods

Study population
We evaluated 980 consecutive patients with CHF caused by ischemia, idiopathic dilated cardiomyopathy, or other disease (i.e. hypertension, valvular disease) admitted to the Heart Failure Unit of Montescano Medical Center for evaluation and treatment of advanced heart failure. All patients, in stable condition and receiving optimized therapy, had a functional evaluation by two-dimensional echocardiography, right heart catheterization, cardiopulmonary tests and laboratory examinations.
Clinical evaluation
We evaluated symptomatic severity by New York Heart Association (NYHA) classification. The clinical examination included assessment of body weight, body mass index (BMI), heart rate, third heart sound, and presence of peripheral or pulmonary edema (rales and/or orthopnea and turgor and/or hepato-jugular reflux).
The presence of other risk factors for CHF, such as increased age, male gender, family history of coronary artery disease, hypertension, smoking and diabetes mellitus were entered into the regression models.
Laboratory testing
Biochemical (serum concentrations of sodium, potassium, urea, creatinine, aspartate transaminase, glutamate transaminase, and bilirubin) and hematologic parameters (hemoglobin concentration, white cell and platelet counts) were measured. A hemoglobin concentration lower than 12 g/dl was used to identify anemic patients.
Cardiac catheterization
Right heart catheterization was performed using a 7 F Swan-Ganz balloon-tipped catheter inserted into the right internal jugular vein and advanced to the pulmonary artery. Measurements were obtained with the patients in a supine position, using a HP transducer connected to a 7005 Marquette polygraph.
Pressure tracings were recorded at a speed of 50 cm/sec on a scale calibrated from 0 to 60 mmHg.
Cardiac output was determined by averaging three consecutive thermodilution curves obtained by injecting 10 ml of saline solution at 0°C into the right atrium.
Right atrial pressure, pulmonary artery pressures and mean pulmonary wedge pressure were recorded. The pulmonary capillary wedge position was confirmed by the appearance of a typical wedge pressure tracing during fluoroscopic observation of the catheter tip during balloon inflation.
Arterial systolic and diastolic blood pressures were measured with a non-invasive method by a calibrated v-lok-cuff connected to a 7005 Marquette system.
Heart rate was monitored continuously from a standard ECG.
Echocardiography
Echocardiographic studies were performed using an HP Sonos 1000 ultrasound system with 2.5 and 3.5 MHz transducers.
We evaluated the diastolic and systolic left ventricular diameters from a parasternal long axis view and calculated left ventricular ejection fraction using a B-mode four-chamber view. 6 The mitral regurgitation jet was evaluated as the ratio between jet area and left atrial area; regurgitation was ranked as mild, moderate or severe. 7 In our analysis we considered moderate or severe mitral regurgitation in contrast to mild or no mitral regurgitation.
Cardiopulmonary test
Cardiopulmonary testing was performed in the upright position on an electronic bicycle. The cardiopulmonary parameters were measured breath by breath with an Oxycon Delta (Seager™ Medical technology) which was calibrated before each test. The following parameters were calculated: basal and peak VO 2 in ml/min/kg of body weight.
End points
In this study the outcome event was cardiac death or urgent heart transplant. Cardiac deaths were those due to heart failure or sudden death; transplants were included in the outcome because we assumed that these patients would have died without transplant.
Non-urgent transplants were not considered in the primary end point analysis.
We considered a death sudden if it occurred within 1 hour of the onset of unexpected symptoms or during sleep in patients who were symptomatically stable during the 24 hours preceding death, or was unwitnessed death and occurred within 1 hour of the patient last being seen alive. Death from heart failure was considered to have occurred in conjunction with a worsening of congestive symptoms.
Statistical analysis
Comparisons between groups for continuous variables were performed by the ANOVA or MannWhitney test when appropriate. Categorical variables were compared by the Chi-square test. The association between prognostic variables and the outcome (cardiac death or urgent heart transplantation) was analysed by univariate and multivariate logistic regression. For each significant prognostic variable, the corresponding odds ratio (OR) and 95% confidence interval (CI) were computed. In building multivariate models, two different sets of candidate variables were considered. The first set included only non-invasively measured parameters, while the second set included both non-invasively and invasively measured parameters. Accordingly, the two models have been referred to as respectively non-invasive and invasive model.
To assess the overall predictive discrimination of each logistic model, we computed the area under the receiver operator characteristic (ROC) curve ob-tained from the model. 8 This area measures the ability of the model to separate patients with poor outcome from those who did not have a poor outcome. A ROC curve area of 0.5 indicates no discrimination power, whereas an area of 1 indicates perfect discrimination. Selection of variables to be included in the multivariate models was performed using the stepwise method. In all hypothesis tests a p value <0.05 was considered statistically significant.
Results
Patients' characteristics
The clinical characteristics of the 980 patients enrolled in the study are shown in table 1. The mean age of the patients was 53±9 years (range 15 to 77 years) and 85% of them were male. The etiology of heart failure was coronary artery disease in 44% (428 patients), a primary dilated cardiomyopathy in 39% (384 patients), and other cardiac disease (hypertension, valvular disease) in 17% (168 patients). Forty-six percent were categorized as having NY-HA functional class III-IV disease and the remaining 54% were in NYHA class I-II. The mean echocardiographic left ventricular ejection fraction was 25±8%. Thus the patients presented a compromised hemodynamic profile and decreased exercise capacity.
Relationship between anemia and clinical findings
Of the total study population, 19% of patients were anemic. Anemia was more frequent in females and in older patients. No differences were found between patients with and without anemia in LVEF, LVEDD, LVESD, deceleration time, cardiac index, history of hypertension, family predisposition, smoking habits, serum sodium and potassium concentrations, and etiology of CHF. However, anemic patients had a lower body mass index (24±3 vs. 25±4 Kg/m 2 p <0.001), a worse functional class (NYHA functional class III-IV 64% vs 41% p <0.001), poorer exercise capacity (12.4 vs. 14.8 ml/kg/min peak VO 2 , p <0.001) and higher right (7±5 vs 5±4 mmHg, p <0.001) and left ventricular filling (21±9 vs. 19±10 p <0. 001) pressures (table 1) .
Outcome events
Over a three-year follow-up there were 288 (29%) outcome events. Cardiac death occurred in 236 (24%) patients; progressive CHF accounted for 141 (60%) of these deaths, while 95 (40%) were sudden. Fifty-two (5%) patients received a heart transplant in Status I. The percentage of patients who therefore had suffered a hard cardiac event was higher among anemic than among non-anemic patients (39% vs. 27% p <001) (figure 1).
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Multivariate logistic analysis
Among all clinical and Biochemical and hematologic non-invasively measured parameters which significantly predicted primary outcome in the univariate analyses, the following set of variables in the multivariate predictive model were predictive (table 4) : NYHA functional class, mitral regurgitation, anemia, LVEF and serum sodium. When we repeated the multivariate analysis including all noninvasive parameters and peak VO 2 , the final model predicting the primary outcome included: NYHA functional class, mitral regurgitation, LVEF, serum sodium and peak VO 2 , but not anemia. In the multivariate model incorporating non-invasive and invasive parameters, the following variables were independent predictors (table 3) : NYHA functional class, mitral regurgitation, LVEF, serum sodium and right atrial pressure. To appraise differences in prognostic accuracy between the various prognostic models (with peak VO 2 or anemia, or RAP), we compared them using ROC curves. The areas under the ROC curves of the three models were not significantly different ( figure 2, table 3 ).
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Univariate analysis
Univariate logistic regression analysis identified many variables that were predictive of cardiac mortality or urgent cardiac transplantation in the threeyear follow-up (table 2) .
We also analyzed the relation between chronic renal failure (CRF) and anemia and found that anemia was more frequent in patients with CRF than in patients with normal renal function (38% vs. 18%; p =0.001), anemia, however, maintained its univariate prognostic value both in CRF patients (p =0.015)
Discussion
The present study, conducted in a large cohort of patients with CHF of different etiologies and with various degrees of cardiac dysfunction, demonstrates that anemia is associated with prognosis in CHF. Our study confirms and extends previous evidence. [3] [4] [5] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] In agreement with previous studies, anemia was associated with a worse NYHA functional class, exercise capacity and hemodynamic profile (table 5). However this study is the first that analyzed the independent prognostic power of anemia among other considered non-invasive and invasive prognostic indices which are validated in routine clinical practice. In agreement with previous studies it identifies the relationship between anemia and a "hard" cardiac event but highlights the fact that the use of complex non-invasive and invasive prognostic models obtained in different settings provides similar prognostic power to that with the simpler measurement of anemia.
This result can be explained by the close physiopathologic relationship that exists between anemia and the different prognostic determinants. 21 
Anemia in chronic heart failure
Several different factors may work together in CHF to cause anemia. Impaired renal function and 128 M. CERESA ET AL. disturbance of erythropoietin metabolism can be associated with anemia; on the other hand, lower Hb can be associated with higher creatinine. Recent data show how the use of erythropoietin can modify prognosis in CHF patients. 4 We analyzed our patients in two groups according to whether they did or did not have renal failure and found that the association between low Hb and increased cardiac mortality was present in both subsets of patients; likewise, in the SOLVD study, anemia was related to an increased risk of mortality after adjustment for renal dysfunction. 11 These apparent discrepancies can be explained by the different etiologies of the anemia in the various CHF populations evaluated. Anemia in CHF is at least partially due to excessive production of cytokines (such as tumor necrosis factor alpha (TNFα)) and leukotrienes that interfere both with the effect of erythropoietin on bone marrow (they inhibit its effect) and the release of stored iron in the reticuloendothelial system. 22 Recent data show that TNFα may suppress both early and late stages of hematopoiesis and can induce programmed cell death with consequent decrease of hematopoiesis. 23 Only the red cell count was decreased in our anemic patients; platelets and white cell counts were similar to those in the non-anemic patients (table 4) . This observation allows us to draw two important implication: first, TNF could play an important role in the genesis of anemia in these patients; second, the anemia cannot be considered simply as the result of hemodilution, or of general illness, because otherwise all the cell lineages would be affected.
Cardiac cachexia due to malnutrition, a catabolic state, malabsorption, and atrophic gastritis can induce anemia in CHF. 24 We analyzed the nutritional state of our population and found that the BMI was lower in anemic patients than in non-anemic ones. Compromised liver function is often associated with chronic heart failure. A conjunction of different causes (hypoxia, chronic congestion, malnutrition) can decrease the biosynthetic capacity of the liver with decreased synthesis of glycine and succinyl-CoA. These alterations could limit the synthesis of the heme group precursor of Δ-aminolevulinate acid and, finally, of hemoglobin. 25, 26 In this scenario the final result is the development of mild normocytic anemia. In our cohort of patients, the anemic ones had poorer liver synthesis function (table 4) .
Different studies underline the role of anemia in modifying the natural outcome of CHF. [27] [28] [29] [30] [31] In this context its prospective prognostic informative content is transferred to already consolidated markers (i.e. NYHA class, mitral regurgitation, volemia, peak VO 2 ).Thus anemia should also be considered as one of chronic conditions that determine a poor prognosis.
Prognostic models
Various sets of prognostic variables for patients with CHF have been proposed in the literature. In a scenario in which it is essential to consider scarce resources, 32 it is important to identify simpler prognostic models that are practical in different settings. In primary care, a simple model containing anemia and other established non-invasive markers can stratify risk and identify patients who should be referred to specialist intensive care. In this simple model the parameters of peak VO 2 and anemia compete. Peak VO 2 showed a greater prognostic power because it combines both oxygen transport capacity (i.e. hemoglobin) but also it's central and peripheral determinants. The multivariate model selects this variable instead of anemia. But cardiopulmonary exercise test (VO 2 ) are rarely performed in the context of community care and their prognostic power is weakened by the wide range of values. 33 In contrast when anemia is considered in the model, prognostic accuracy remains substantially unchanged. Analogous considerations could also be made for invasive variables.
Open clinical questions
Although our results once again underline the strong link between anemia, CHF and mortality, there are many unclear areas in this relationship that deserve further investigation. Currently there are no data about the type of anemia in patients with chronic heart failure. Silverberg analyzed the correlation between chronic diseases (such as chronic renal failure, chronic heart failure, chronic inflammatory bowel disease and rheumatoid arthritis) and anemia. 4 Differences between anemia Classifica-129 ANEMIA AND CHRONIC HEART FAILURE Figure 2. -ROC curves for the combined end-point of cardiac mortality or urgent heart transplantation using non-invasive and invasive models. tion, population characteristics, study design, therapeutic optimization limits the comparison between several studies. The prognostic power of anemia in many reports was not adjusted for all established non-invasive and invasive prognostic variables (table 5) . Gender and diastolic heart failure have not been evaluated in the different studies. Silverberg showed favorable clinical results after the use of erythropoietin and iron, but in a randomized clinical trial in anemic patients with end-stage renal and heart failure, normalization of hematocrit produced by erythropoietin and iron infusion was associated with increased myocardial infarction. 34 Currently there are few data about the relationship between hemoglobin changes and long term prognosis in CHF patients. 20 
Study limitations
This study has limitations. First, we examined selected patients who were entering a heart transplantation program. Second, elderly patients, those with diastolic heart failure, and women were underrepresented. Third, the etiology of the anemia was not studied. Finally, several iatrogenic causes of anemia and possible therapeutic treatments undertaken, which could have conditioned the clinical outcome, were not considered.
Conclusions
The present study was conducted in a large cohort of patients with CHF of different etiology and degree of cardiac dysfunction. The study demonstrates that anemia was associated with a worse NY-HA functional class, exercise capacity and hemodynamic profile. We found that the relationship between anemia and mortality is independent of noninvasive established prognostic factors. In a selected prognostic model using simple non-invasive predictors which include anemia, the addition of complex independent predictors did not increase the accuracy of the model in predicting cardiac mortality. Supplementary studies are needed to understand the etiology and pathology of anemia in CHF patients in order to verify whether treatment of anemia will indeed improve survival.
